Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bon Natural Life's earnings before interest and taxes (EBIT) for the
six
months ended in Sep. 2025 was $-1.82 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2025 was $-1.34 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Bon Natural Life's annualizedROC % for the quarter that ended in Sep. 2025 was -6.19%.
Bon Natural Life's annualizedROC (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was -9.18%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Bon Natural Life's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was -7.37%.
Bon Natural Life (NAS:BON) EBIT Explanation
1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Bon Natural Life's annualizedROC % for the quarter that ended in Sep. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bon Natural Life EBIT Related Terms
Bon Natural Life EBIT Historical Data
* Premium members only.
The historical data trend for Bon Natural Life's EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Bon Natural Life's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bon Natural Life EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Bon Natural Life's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Bon Natural Life's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.34 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bon Natural Life (BON) has a EBIT of $-1.34 Mil as of Sep. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Bon Natural Life.
Is Bon Natural Life's EBIT too high?
Bon Natural Life's current EBIT is $-1.34 Mil. Overall, Bon Natural Life has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bon Natural Life's EBIT compare to SNES and YMAT?
Bon Natural Life's EBIT of $-1.34 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Chemicals company?
A good EBIT depends on the Chemicals industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Bon Natural Life. Bon Natural Life's current EBIT is $-1.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bon Natural Life stock overvalued right now?
Based on GuruFocus' analysis, Bon Natural Life (BON) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.76, compared to a current price of $1.14 — trading 50% above its estimated fair value. The current EBIT is $-1.34 Mil. Bon Natural Life's overall GF Score™ is 42/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Bon Natural Life (BON), the current EBIT is $-1.34 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bon Natural Life (BON) Overvalued in 2026?
Based on GuruFocus' analysis, Bon Natural Life stock appears to be overvalued.
The current stock price of $1.14 is trading 50% above its estimated GF Value™ of $0.76.
GuruFocus considers Bon Natural Life to be Significantly Overvalued.
Key valuation signals for BON:
EBIT: $-1.34 Mil
GF Value™: $0.76 vs. price of $1.14 (50% above fair value)
No single metric tells the full story. See the BON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.
42GF Score
Get the complete analysis for BON
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BON has been successfully added to your 
